12 October 2023


Ranok Therapeutics to Present at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics



- CSO Kevin Foley to highlight application of company’s innovative CHAMPâ technology to target ERK5, an emerging cancer target



Read More >






11 March 2024


Ranok Therapeutics Expands Clinical Testing of CHAMPâ BRD4 Protein Degrader RNK05047 to China


-- Study follows ongoing Phase 1 trial in U.S. and will enroll patients in China to evaluate the first protein degrader developed using Ranok’s innovative CHAMPâ technology


Read More >






4 April 2024


Ranok Therapeutics to Present at American Association for Cancer Research (AACR) Annual Meeting 2024


--Poster presentations to highlight application of company's innovative CHAMP® technology to important cancer targets including KRAS


Read More >






Events & Presentations
Press Releases & Media